NASDAQ:AKRX - Akorn Stock Price, Forecast & News

Akorn trades on the NASDAQ under the ticker symbol "AKRX."

Akorn, Inc. (NASDAQ:AKRX) issued its earnings results on Thursday, October, 31st. The company reported $0.02 EPS for the quarter, beating analysts' consensus estimates of ($0.04) by $0.06. The business earned $176.24 million during the quarter, compared to analyst estimates of $176.15 million. Akorn had a negative return on equity of 19.95% and a negative net margin of 53.62%. Akorn's revenue was up 6.4% on a year-over-year basis. During the same period in the prior year, the company posted ($0.06) earnings per share. View Akorn's Earnings History.

3 Wall Street analysts have issued 12 month price objectives for Akorn's stock. Their forecasts range from $4.00 to $8.00. On average, they anticipate Akorn's stock price to reach $5.67 in the next year. This suggests a possible upside of 342.7% from the stock's current price. View Analyst Price Targets for Akorn.

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Akorn in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Akorn.

Headlines about AKRX stock have been trending somewhat negative on Monday, InfoTrie Sentiment Analysis reports. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Akorn earned a media sentiment score of -1.4 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View News Stories for Akorn.

Akorn saw a drop in short interest during the month of January. As of January 15th, there was short interest totalling 5,820,000 shares, a drop of 31.6% from the December 31st total of 8,510,000 shares. Based on an average daily trading volume, of 2,360,000 shares, the short-interest ratio is currently 2.5 days. Currently, 6.1% of the shares of the company are short sold. View Akorn's Current Options Chain.

Some companies that are related to Akorn include Johnson & Johnson (JNJ), Pfizer (PFE), Merck & Co., Inc. (MRK), Eli Lilly And Co (LLY), AbbVie (ABBV), Bristol-Myers Squibb (BMY), Zoetis (ZTS), Allergan (AGN), Mylan (MYL), Jazz Pharmaceuticals (JAZZ), Perrigo (PRGO), The Medicines (MDCO), Horizon Therapeutics (HZNP), Nektar Therapeutics (NKTR) and Zogenix (ZGNX).

Based on aggregate information from My MarketBeat watchlists, some companies that other Akorn investors own include Celgene (CELG), Integrated Device Technology (IDTI), Skechers USA (SKX), Rite Aid (RAD), Lannett (LCI), Bank of America (BAC), Quantenna Communications (QTNA), Ulta Beauty (ULTA), Paycom Software (PAYC) and Square (SQ).

Akorn's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Assenagon Asset Management S.A. (0.10%), Eqis Capital Management Inc. (0.05%), Arizona State Retirement System (0.05%) and Benin Management CORP (0.02%). Company insiders that own Akorn stock include Alan D Weinstein, Joseph Bonaccorsi, Steven J Meyer and Terry Allison Rappuhn. View Institutional Ownership Trends for Akorn.

AKRX stock was sold by a variety of institutional investors in the last quarter, including Assenagon Asset Management S.A. and Arizona State Retirement System. View Insider Buying and Selling for Akorn.

AKRX stock was purchased by a variety of institutional investors in the last quarter, including Eqis Capital Management Inc. and Benin Management CORP. Company insiders that have bought Akorn stock in the last two years include Alan D Weinstein, Joseph Bonaccorsi, Steven J Meyer and Terry Allison Rappuhn. View Insider Buying and Selling for Akorn.

Shares of AKRX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of AKRX stock can currently be purchased for approximately $1.28.

Akorn has a market capitalization of $161.47 million and generates $694.02 million in revenue each year. The company earns $-401,910,000.00 in net income (profit) each year or ($0.36) on an earnings per share basis. Akorn employs 2,191 workers across the globe.View Additional Information About Akorn.

The official website for Akorn is http://www.akorn.com/.

Akorn's mailing address is 1925 WEST FIELD COURT SUITE 300, LAKE FOREST IL, 60045. The company can be reached via phone at 847-279-6100 or via email at [email protected]